FDAFDA · Food and drugs·Recall number D-1034-2016
Librax (5 mg chlordiazepoxide HCl and 2.5 mg clidinium bromide) capsules, 100-count bottle, Rx Only, Manufactured in Canada by: Valeant Pharmaceuticals International, Inc., Steinbach, MB R5G 1Z7 Canada; Manufactured for: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807, NDC 0187-4100-10.
Published June 22, 2016 · Recall initiated: April 18, 2015
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- LIBRAX
- Manufacturer
- Valeant Pharmaceuticals North America LLC
- Distributor
- Nationwide and Puerto Rico
- UPC
- 0301874100101
- Lot
- Lot #: 14L024P, Exp 06/16; and 15E029P, Exp 04/19
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.